Norbert W. Bischofberger's Insider Trades & SAST Disclosures
Norbert W. Bischofberger's most recent trade in Kronos Bio Inc was a trade of 410,848 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on June 27, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Norbert W. Bischofberger.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kronos Bio Inc | Norbert W. Bischofberger | Director, PRESIDENT & CEO | Purchase of securities on an exchange or from another person at price $ 1.17 per share. | 27 Jun 2024 | 410,848 | 10,597,468 | - | 1.2 | 478,843 | Common Stock |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, PRESIDENT & CEO | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 27 Jun 2024 | 204,670 | 10,802,138 | - | 1.2 | 254,957 | Common Stock |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, PRESIDENT & CEO | Purchase of securities on an exchange or from another person at price $ 0.88 per share. | 10 Jun 2024 | 1,378,901 | 5,749,395 | - | 0.9 | 1,208,469 | Common Stock |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, PRESIDENT & CEO | Purchase of securities on an exchange or from another person at price $ 1.24 per share. | 10 Jun 2024 | 881,913 | 7,375,616 | - | 1.2 | 1,096,041 | Common Stock |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, PRESIDENT & CEO | Purchase of securities on an exchange or from another person at price $ 1.09 per share. | 10 Jun 2024 | 744,308 | 6,493,703 | - | 1.1 | 814,571 | Common Stock |
| Morphic Holding Inc | Norbert W. Bischofberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 23,168 | 23,168 | - | - | Common Stock | |
| Vir Biotechnology Inc | Norbert W. Bischofberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Norbert W. Bischofberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vir Biotechnology Inc | Norbert W. Bischofberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 16,000 | 16,000 (0%) | 0% | 0 | Common Stock | |
| Kronos Bio Inc | W. Norbert Bischofberger | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 699,800 | 699,800 | - | - | Employee Stock Option (Right to Buy) | |
| Kronos Bio Inc | W. Norbert Bischofberger | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 270,339 | 2,811,004 | - | 0 | Common Stock | |
| Morphic Holding Inc | Norbert W. Bischofberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 12,535 | 12,535 | - | - | Director Stock Option (Right to Buy) | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 570,868 | 570,868 | - | - | Employee Stock Option (Right to Buy) | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 3.78 per share. | 17 May 2022 | 300,000 | 809,609 | - | 3.8 | 1,134,510 | Common Stock |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 3.72 per share. | 17 May 2022 | 206,198 | 509,609 | - | 3.7 | 768,046 | Common Stock |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 3.83 per share. | 17 May 2022 | 90,931 | 303,411 | - | 3.8 | 348,529 | Common Stock |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 400,000 | 400,000 | - | - | Employee Stock Option (Right to Buy) | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 12.08 per share. | 06 Dec 2021 | 14,356 | 212,480 | - | 12.1 | 173,492 | Common Stock |
| Morphic Holding Inc | Norbert W. Bischofberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 12,000 | 12,000 | - | - | Director Stock Option (right to buy) | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 297,186 | 297,186 | - | - | Employee Stock Option (Right to Buy) | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 198,124 | 198,124 | - | 0 | Common Stock | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 1,651,576 | 4,089,238 | - | - | Common Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 1,565,475 | 0 | - | - | Series A Preferred Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 316,501 | 2,437,662 | - | - | Common Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 300,001 | 0 | - | - | Series Seed Preferred Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 263,750 | 263,750 | - | - | Common Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 263,750 | 263,750 | - | - | Common Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 263,750 | 263,750 | - | - | Common Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 263,750 | 263,750 | - | - | Common Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 250,000 | 0 | - | - | Series Seed Preferred | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 250,000 | 0 | - | - | Series Seed Preferred Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 250,000 | 0 | - | - | Series Seed Preferred Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 250,000 | 0 | - | - | Series Seed Preferred Stock | ||
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | 14 Oct 2020 | 185,758 | 4,274,996 | - | 16.2 | 2,999,992 | Common Stock | |
| Kronos Bio Inc | Norbert W. Bischofberger | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 14 Oct 2020 | 95,500 | 4,370,496 | - | 19 | 1,814,500 | Common Stock |
| Morphic Holding Inc | Norbert W. Bischofberger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 12,000 | 12,000 | - | - | Director Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges